Around 4,000 people are set to benefit from a change in treatment for early breast cancer following provisional approval by NICE of abemaciclib in combination with hormone therapy.
A new treatment that increases the chance of a successful kidney transplant has been recommended by NICE in final draft guidance.
NICE has published final draft guidance which recommends icosapent ethyl for reducing the risk of heart attacks and strokes in adults who have raised blood fats.
A potentially life-changing treatment has been recommended for people with short bowel syndrome who are aged 1 year and above.
NICE has outlined what aspects of menopause care will be updated in upcoming guidance, including areas where more research is needed.
People with triple negative breast cancer that has spread to other parts of the body may soon benefit from pembrolizumab in combination with chemotherapy.
Page 32 of 42